AstraZeneca Plc’s Covid-19 vaccine recently, adding to the numbers that have caused European countries to adopt precautionary measures.The total number of cases as of March 24 is now 30, the Medicines and Healthcare Products Regulatory Agency said in a statement Thursday.
There were no reports of the same reactions to the BioNTech/Pfizer vaccine, the agency said.AstraZeneca’s vaccine, developed with the University of Oxford, is under mounting scrutiny and has faced dwindling support in Europe.
Still, countries are counting on the shot to help them exit the pandemic, and millions of doses have been administered across the region.The U.K.